High Frequency and Diversity of Antimicrobial Activities Produced by Nasal Staphylococcus Strains against Bacterial Competitors

PLoS Pathogens

Volumn 12, Issue 8, 2016, Pages

  Janek, Daniela ^a,b,c   Zipperer, Alexander ^a,b   Kulik, Andreas ^a,b   Krismer, Bernhard ^a,b   Peschel, Andreas ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b German Centre for Infection Research (DZIF)   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; LANTIBIOTIC; NUKACIN; UNCLASSIFIED DRUG;

AGAR DIFFUSION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; ELECTROPORATION; ELECTROSPRAY MASS SPECTROMETRY; GENE FREQUENCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL DIVERSITY; MICROFLORA; MULTILOCUS SEQUENCE TYPING; NASAL FLORA; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIZE EXCLUSION CHROMATOGRAPHY; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; ULTRAVIOLET SPECTROPHOTOMETRY; ANTIBIOSIS; BIOSYNTHESIS; METABOLISM; MICROBIOLOGY; NOSE; PHYSIOLOGY;

ANTIBIOSIS; BACTERIOCINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MICROBIOTA; NOSE; POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STAPHYLOCOCCUS;

EID: 84984813443     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005812     Document Type: Article

References (68)

1. Rosenthal M, Goldberg D, Aiello A, Larson E, Foxman B, Skin microbiota: microbial community structure and its potential association with health and disease. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2011;11(5):839–48. Epub 2011/04/06. doi: 10.1016/j.meegid.2011.03.02221463709; PubMed Central PMCID: PMC3114449.
2. Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B, The intestinal microbiome in early life: health and disease. Frontiers in immunology. 2014;5:427. Epub 2014/09/25. doi: 10.3389/fimmu.2014.0042725250028; PubMed Central PMCID: PMC4155789.
3. Huttenhower C GD, Knight R, Abubucker S, Badger JH, Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. Epub 2012/06/16. doi: 10.1038/nature1123422699609; PubMed Central PMCID: PMC3564958.
4. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R, Bacterial community variation in human body habitats across space and time. Science. 2009;326(5960):1694–7. Epub 2009/11/07. doi: 10.1126/science.117748619892944; PubMed Central PMCID: PMC3602444.
5. Wos-Oxley ML, Plumeier I, von Eiff C, Taudien S, Platzer M, Vilchez-Vargas R, et al. A poke into the diversity and associations within human anterior nare microbial communities. ISME J. 2010;4(7):839–51. Epub 2010/02/26. ismej201015 [pii] doi: 10.1038/ismej.2010.1520182526.
6. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R, Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30. Epub 2012/09/14. doi: 10.1038/nature1155022972295; PubMed Central PMCID: PMC3577372.
7. Pelton SI, Regulation of bacterial trafficking in the nasopharynx. Paediatric respiratory reviews. 2012;13(3):150–3. Epub 2012/06/26. doi: 10.1016/j.prrv.2012.04.00122726870; PubMed Central PMCID: PMC3383606.
8. Fredheim EG, Flaegstad T, Askarian F, Klingenberg C, Colonisation and interaction between S. epidermidis and S. aureus in the nose and throat of healthy adolescents. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2014. Epub 2014/08/01. doi: 10.1007/s10096-014-2197-525079512.
9. Cornforth DM, Foster KR, Competition sensing: the social side of bacterial stress responses. Nature reviews Microbiology. 2013;11(4):285–93. Epub 2013/03/05. doi: 10.1038/nrmicro297723456045.
10. Traxler MF, Watrous JD, Alexandrov T, Dorrestein PC, Kolter R, Interspecies interactions stimulate diversification of the Streptomyces coelicolor secreted metabolome. mBio. 2013;4(4). Epub 2013/08/22. doi: 10.1128/mBio.00459-1323963177; PubMed Central PMCID: PMC3747584.
11. Chandler JR, Heilmann S, Mittler JE, Greenberg EP, Acyl-homoserine lactone-dependent eavesdropping promotes competition in a laboratory co-culture model. ISME J. 2012;6(12):2219–28. Epub 2012/07/06. doi: 10.1038/ismej.2012.6922763647; PubMed Central PMCID: PMC3504959.
12. Krismer B, Liebeke M, Janek D, Nega M, Rautenberg M, Hornig G, et al. Nutrient Limitation Governs Staphylococcus aureus Metabolism and Niche Adaptation in the Human Nose. PLoS pathogens. 2014;10(1):e1003862. Epub 2014/01/24. doi: 10.1371/journal.ppat.100386224453967.
13. Cameron EA, Kwiatkowski KJ, Lee BH, Hamaker BR, Koropatkin NM, Martens EC, Multifunctional nutrient-binding proteins adapt human symbiotic bacteria for glycan competition in the gut by separately promoting enhanced sensing and catalysis. mBio. 2014;5(5). Epub 2014/09/11. doi: 10.1128/mBio.01441-1425205092.
14. Quercia S, Candela M, Giuliani C, Turroni S, Luiselli D, Rampelli S, et al. From lifetime to evolution: timescales of human gut microbiota adaptation. Frontiers in microbiology. 2014;5:587. Epub 2014/11/20. doi: 10.3389/fmicb.2014.0058725408692; PubMed Central PMCID: PMC4219431.
15. Lowy FD, Staphylococcus aureus infections. New England Journal of Medicine. 1998;339(8):520–32. 9709046
16. Powers ME, Bubeck Wardenburg J, Igniting the Fire: Staphylococcus aureus Virulence Factors in the Pathogenesis of Sepsis. PLoS pathogens. 2014;10(2):e1003871. Epub 2014/02/20. doi: 10.1371/journal.ppat.100387124550724; PubMed Central PMCID: PMC3923759.
17. von Eiff C, Becker K, Machka K, Stammer H, Peters G, Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. The New England journal of medicine. 2001;344(1):11–6. Epub 2001/01/04. doi: 10.1056/NEJM20010104344010211136954.
18. Weidenmaier C, Goerke C, Wolz C, Staphylococcus aureus determinants for nasal colonization. Trends in microbiology. 2012;20(5):243–50. Epub 2012/04/13. doi: 10.1016/j.tim.2012.03.00422494802.
19. Abad CL, Pulia MS, Safdar N, Does the nose know? An update on MRSA decolonization strategies. Current infectious disease reports. 2013;15(6):455–64. Epub 2013/10/24. doi: 10.1007/s11908-013-0364-y24150839; PubMed Central PMCID: PMC4258870.
20. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, et al. Targeted versus universal decolonization to prevent ICU infection. The New England journal of medicine. 2013;368(24):2255–65. Epub 2013/05/31. doi: 10.1056/NEJMoa120729023718152.
21. Johannessen M, Sollid JE, Hanssen AM, Host- and microbe determinants that may influence the success of S. aureus colonization. Frontiers in cellular and infection microbiology. 2012;2:56. Epub 2012/08/25. doi: 10.3389/fcimb.2012.0005622919647; PubMed Central PMCID: PMC3417514.
22. Andersen PS, Larsen LA, Fowler VG, Jr.Stegger M, Skov RL, Christensen K, Risk factors for Staphylococcus aureus nasal colonization in Danish middle-aged and elderly twins. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2013;32(10):1321–6. Epub 2013/05/10. doi: 10.1007/s10096-013-1882-023657294; PubMed Central PMCID: PMC3775156.
23. Sandiford S, Upton M, Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci. Antimicrobial agents and chemotherapy. 2012;56(3):1539–47. Epub 2011/12/14. doi: 10.1128/AAC.05397-1122155816; PubMed Central PMCID: PMC3294953.
24. Nascimento Jdos S, Coelho ML, Ceotto H, Potter A, Fleming LR, Salehian Z, et al. Genes involved in immunity to and secretion of aureocin A53, an atypical class II bacteriocin produced by Staphylococcus aureus A53. Journal of bacteriology. 2012;194(4):875–83. Epub 2011/12/14. doi: 10.1128/JB.06203-1122155775; PubMed Central PMCID: PMC3272949.
25. Navaratna MA, Sahl HG, Tagg JR, Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Applied and environmental microbiology. 1998;64(12):4803–8. Epub 1998/12/03. 9835565; PubMed Central PMCID: PMC90925.
26. Bierbaum G, Sahl HG, Lantibiotics: mode of action, biosynthesis and bioengineering. Current pharmaceutical biotechnology. 2009;10(1):2–18. Epub 2009/01/20. 19149587.
27. Cotter PD, Ross RP, Hill C, Bacteriocins—a viable alternative to antibiotics?Nature reviews Microbiology. 2013;11(2):95–105. Epub 2012/12/27. doi: 10.1038/nrmicro293723268227.
28. Navaratna MA, Sahl HG, Tagg JR, Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect Immun. 1999;67(8):4268–71. Epub 1999/07/23. 10417203; PubMed Central PMCID: PMC96736.
29. Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR, The human nasal microbiota and Staphylococcus aureus carriage. PloS one. 2010;5(5):e10598. Epub 2010/05/26. doi: 10.1371/journal.pone.001059820498722; PubMed Central PMCID: PMC2871794.
30. Kaspar U, Kriegeskorte A, Schubert T, Peters G, Rudack C, Pieper DH, et al. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ Microbiol. 2015. doi: 10.1111/1462-2920.1289125923378.
31. Liu CM, Price LB, Hungate BA, Abraham AG, Larsen LA, Christensen K, et al. Staphylococcus aureus and the ecology of the nasal microbiome. Sci Adv. 2015;1(5):e1400216. doi: 10.1126/sciadv.140021626601194; PubMed Central PMCID: PMCPMC4640600.
32. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F, Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. The Journal of biological chemistry. 1999;274(13):8405–10. Epub 1999/03/20. 10085071.
33. Coates R, Moran J, Horsburgh MJ, Staphylococci: colonizers and pathogens of human skin. Future microbiology. 2014;9(1):75–91. Epub 2013/12/18. doi: 10.2217/fmb.13.14524328382.
34. Burian M, Wolz C, Goerke C, Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans. PloS one. 2010;5(4):e10040. Epub 2010/04/14. doi: 10.1371/journal.pone.001004020386721; PubMed Central PMCID: PMC2850373.
35. Archer NK, Harro JM, Shirtliff ME, Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect Immun. 2013;81(6):2070–5. Epub 2013/03/27. doi: 10.1128/IAI.00084-1323529621; PubMed Central PMCID: PMC3676016.
36. Seki M, Iida K, Saito M, Nakayama H, Yoshida S, Hydrogen peroxide production in Streptococcus pyogenes: involvement of lactate oxidase and coupling with aerobic utilization of lactate. Journal of bacteriology. 2004;186(7):2046–51. Epub 2004/03/19. 15028688; PubMed Central PMCID: PMC374426.
37. Selva L, Viana D, Regev-Yochay G, Trzcinski K, Corpa JM, Lasa I, et al. Killing niche competitors by remote-control bacteriophage induction. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(4):1234–8. Epub 2009/01/15. doi: 10.1073/pnas.080960010619141630; PubMed Central PMCID: PMC2633583.
38. Asaduzzaman SM, Nagao J, Iida H, Zendo T, Nakayama J, Sonomoto K, Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrobial agents and chemotherapy. 2009;53(8):3595–8. Epub 2009/06/10. doi: 10.1128/AAC.01623-0819506061; PubMed Central PMCID: PMC2715603.
39. Wilaipun P, Zendo T, Okuda K, Nakayama J, Sonomoto K, Identification of the nukacin KQU-131, a new type-A(II) lantibiotic produced by Staphylococcus hominis KQU-131 isolated from Thai fermented fish product (Pla-ra). Bioscience, biotechnology, and biochemistry. 2008;72(8):2232–5. Epub 2008/08/08. doi: 10.1271/bbb.8023918685189.
40. Dobson A, Cotter PD, Ross RP, Hill C, Bacteriocin production: a probiotic trait?Applied and environmental microbiology. 2012;78(1):1–6. Epub 2011/11/01. doi: 10.1128/AEM.05576-1122038602; PubMed Central PMCID: PMC3255625.
41. Bogaert D, Keijser B, Huse S, Rossen J, Veenhoven R, van Gils E, et al. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PloS one. 2011;6(2):e17035. Epub 2011/03/10. doi: 10.1371/journal.pone.001703521386965; PubMed Central PMCID: PMC3046172.
42. Allen EK, Koeppel AF, Hendley JO, Turner SD, Winther B, Sale MM, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome. 2014;2:22. Epub 2014/07/17. doi: 10.1186/2049-2618-2-2225028608; PubMed Central PMCID: PMC4098959.
43. Lemon KP, Klepac-Ceraj V, Schiffer HK, Brodie EL, Lynch SV, Kolter R, Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. mBio. 2010;1(3). Epub 2010/08/31. doi: 10.1128/mBio.00129-1020802827; PubMed Central PMCID: PMC2925076.
44. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465(7296):346–9. Epub 2010/05/21. doi: 10.1038/nature0907420485435.
45. Yan M, Pamp SJ, Fukuyama J, Hwang PH, Cho DY, Holmes S, et al. Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell host & microbe. 2013;14(6):631–40. Epub 2013/12/18. doi: 10.1016/j.chom.2013.11.00524331461; PubMed Central PMCID: PMC3902146.
46. Uehara Y, Nakama H, Agematsu K, Uchida M, Kawakami Y, Abdul Fattah AS, et al. Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. The Journal of hospital infection. 2000;44(2):127–33. Epub 2000/02/09. doi: 10.1053/jhin.1999.068010662563.
47. Peschel A, Sahl HG, The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nature reviews Microbiology. 2006;4(7):529–36. Epub 2006/06/17. nrmicro1441 [pii] doi: 10.1038/nrmicro144116778838.
48. Poovelikunnel T, Gethin G, Humphreys H, Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. J Antimicrob Chemother. 2015;70(10):2681–92. doi: 10.1093/jac/dkv16926142407.
49. Lindsay JA, Staphylococcus aureus genomics and the impact of horizontal gene transfer. International journal of medical microbiology: IJMM. 2014;304(2):103–9. Epub 2014/01/21. doi: 10.1016/j.ijmm.2013.11.01024439196.
50. Matilla MA, Fang X, Salmond GP, Viunalikeviruses are environmentally common agents of horizontal gene transfer in pathogens and biocontrol bacteria. ISME J. 2014;8(10):2143–7. Epub 2014/08/15. doi: 10.1038/ismej.2014.15025118075; PubMed Central PMCID: PMC4184006.
51. Smillie C, Garcillan-Barcia MP, Francia MV, Rocha EP, de la Cruz F, Mobility of plasmids. Microbiology and molecular biology reviews: MMBR. 2010;74(3):434–52. Epub 2010/09/02. doi: 10.1128/MMBR.00020-1020805406; PubMed Central PMCID: PMC2937521.
52. Winstel V, Liang C, Sanchez-Carballo P, Steglich M, Munar M, Broker BM, et al. Wall teichoic acid structure governs horizontal gene transfer between major bacterial pathogens. Nature communications. 2013;4:2345. Epub 2013/08/24. doi: 10.1038/ncomms334523965785; PubMed Central PMCID: PMC3903184.
53. Nonaka L, Maruyama F, Miyamoto M, Miyakoshi M, Kurokawa K, Masuda M, Novel conjugative transferable multiple drug resistance plasmid pAQU1 from Photobacterium damselae subsp. damselae isolated from marine aquaculture environment. Microbes and environments / JSME. 2012;27(3):263–72. Epub 2012/03/27. 22446310; PubMed Central PMCID: PMC4036041.
54. Peters JE, Fricker AD, Kapili BJ, Petassi MT, Heteromeric transposase elements: generators of genomic islands across diverse bacteria. Molecular microbiology. 2014;93(6):1084–92. Epub 2014/08/06. doi: 10.1111/mmi.1274025091064.
55. Roy U, Islam MR, Nagao J, Iida H, Mahin AA, Li M, et al. Bactericidal activity of nukacin ISK-1: an alternative mode of action. Bioscience, biotechnology, and biochemistry. 2014;78(7):1270–3. doi: 10.1080/09168451.2014.91848525229869.
56. Islam MR, Nishie M, Nagao J, Zendo T, Keller S, Nakayama J, et al. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. J Am Chem Soc. 2012;134(8):3687–90. doi: 10.1021/ja300007h22329487.
57. Santagati M, Scillato M, Patane F, Aiello C, Stefani S, Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol. 2012;65(1):23–31. doi: 10.1111/j.1574-695X.2012.00928.x22243526.
58. Kruszewska D, Sahl HG, Bierbaum G, Pag U, Hynes SO, Ljungh A, Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother. 2004;54(3):648–53. doi: 10.1093/jac/dkh38715282239.
59. Green MR, Sambrook J, Molecular cloning: a laboratory manual: Cold Spring Harbor Laboratory PressNew York; 2012.
60. Augustin J, Gotz F, Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS microbiology letters. 1990;54(1–3):203–7. Epub 1990/01/01. 2182373.
61. Winstel V, Kuhner P, Salomon F, Larsen J, Skov R, Hoffmann W, et al. Wall Teichoic Acid Glycosylation Governs Staphylococcus aureus Nasal Colonization. mBio. 2015;6(4):e00632. doi: 10.1128/mBio.00632-1526126851; PubMed Central PMCID: PMCPMC4488942.
62. Baum C, Haslinger-Loffler B, Westh H, Boye K, Peters G, Neumann C, et al. Non-spa-typeable clinical Staphylococcus aureus strains are naturally occurring protein A mutants. Journal of clinical microbiology. 2009;47(11):3624–9. doi: 10.1128/JCM.00941-0919759222; PubMed Central PMCID: PMCPMC2772612.
63. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. Journal of clinical microbiology. 2003;41(12):5442–8. 14662923; PubMed Central PMCID: PMCPMC309029.
64. Neubauer H, Pantel I, Gotz F, Molecular characterization of the nitrite-reducing system of Staphylococcus carnosus. Journal of bacteriology. 1999;181(5):1481–8. Epub 1999/02/27. 10049379; PubMed Central PMCID: PMC93537.
65. Gutierrez JA, Crowley PJ, Brown DP, Hillman JD, Youngman P, Bleiweis AS, Insertional mutagenesis and recovery of interrupted genes of Streptococcus mutans by using transposon Tn917: preliminary characterization of mutants displaying acid sensitivity and nutritional requirements. Journal of bacteriology. 1996;178(14):4166–75. Epub 1996/07/01. 8763945; PubMed Central PMCID: PMC178174.
66. Monk IR, Shah IM, Xu M, Tan MW, Foster TJ, Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. mBio. 2012;3(2). Epub 2012/03/22. doi: 10.1128/mBio.00277-1122434850; PubMed Central PMCID: PMC3312211.
67. Leibig M, Krismer B, Kolb M, Friede A, Gotz F, Bertram R, Marker removal in staphylococci via Cre recombinase and different lox sites. Applied and environmental microbiology. 2008;74(5):1316–23. Epub 2008/01/01. doi: 10.1128/AEM.02424-0718165371; PubMed Central PMCID: PMC2258651.
68. Bruckner R, A series of shuttle vectors for Bacillus subtilis and Escherichia coli. Gene. 1992;122(1):187–92. Epub 1992/12/01. 1452028.